New findings suggest that a therapeutic approach must combine two different drugs, a SERD to degrade ER and a MEK inhibitor to inhibit Ras downstream signaling, in order to effectively treat neurofibromin-depleted ER+ breast cancer.
Doctors at the Mesothelioma Treatment Center at Baylor College of Medicine and Baylor St. Luke’s Medical Center are now offering mesothelioma patients a new FDA-approved device as part of their treatment plan
Scientists at Baylor College of Medicine have found new evidence that glioma, a lethal form of brain cancer, alters the activity of neighboring neurons, accelerating a vicious cycle that drives tumor-associated epilepsy and tumor progression.
New results from a study showed an association between prolonged enterovirus infection and the development of autoimmunity to the insulin-producing pancreatic beta-cells that precedes type 1 diabetes (T1D).
Researchers examined children treated with two different kinds of radiotherapy—proton radiotherapy and photon radiotherapy—and found those treated with proton radiotherapy had less intellectual decline.
Researchers reported that profiling the bone marrow “metabolome" at the time of pediatric acute lymphoblastic leukemia diagnosis enabled them to identify patients who were most likely to respond poorly to treatment.